Background: Group A Streptococcus (GAS) is a ubiquitous human pathogen responsible for an unrivalled range of clinical disease. The spectrum of GAS disease includes invasive infections such as bacteraemia, necrotising fasciitis and meningitis. There are few data on the impact of invasive GAS in Australia in children.
Methods: Between 2014 and 2016, we established surveillance for invasive GAS disease at the Royal Children’s Hospital in Melbourne. This project comprises an Australia-wide roll out of surveillance to six Australian paediatric hospitals in 2017. The aims of the project are:
Results: In this presentation we outline the methods in establishing national surveillance for paediatric invasive GAS disease in Australia, including case definitions, laboratory techniques and coordination, as well as describing the surveillance network.
Discussion: Understanding the incidence, impact, and molecular epidemiology of invasive GAS disease in Australian children is an important step in raising awareness and advancing the GAS research agenda to promote development of improved management and preventive strategies, including vaccination.